Clinical Trials
5 trialsNCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT02748798 2024-10-15
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Thunder Bay Regional Health Research Institute
Phase EARLY_PHASE1 Terminated
NCT04489862 2020-07-28
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Unknown
NCT01413451 2019-12-17
Amatuximab for High Mesothelin Cancers
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT04056026 2019-09-23
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
ProgenaBiome
Phase EARLY_PHASE1 Completed